Vanguard Group’s AbbVie ABBV Stock Holding History

Vanguard Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$32.9B	Buy	177,298,707 +3,380,842	+2%	+$628M	0.53%	23
2025 Q1	$36.4B	Buy	173,917,865 +845,787	+0.5%	+$177M	0.66%	21
2024 Q4	$30.8B	Buy	173,072,078 +1,424,237	+0.8%	+$253M	0.54%	23
2024 Q3	$33.9B	Buy	171,647,841 +988,295	+0.6%	+$195M	0.61%	22
2024 Q2	$29.3B	Buy	170,659,546 +282,800	+0.2%	+$48.5M	0.56%	22
2024 Q1	$31B	Buy	170,376,746 +9,978,415	+6%	+$1.82B	0.61%	21
2023 Q4	$24.9B	Sell	160,398,331 -349,024	-0.2%	-$54.1M	0.54%	22
2023 Q3	$24B	Buy	160,747,355 +1,450,089	+0.9%	+$216M	0.59%	22
2023 Q2	$21.5B	Sell	159,297,266 -1,169,081	-0.7%	-$158M	0.51%	24
2023 Q1	$25.6B	Buy	160,466,347 +2,148,795	+1%	+$342M	0.65%	21
2022 Q4	$25.6B	Buy	158,317,552 +2,295,138	+1%	+$371M	0.7%	20
2022 Q3	$20.9B	Buy	156,022,414 +2,442,663	+2%	+$328M	0.62%	22
2022 Q2	$23.5B	Buy	153,579,751 +3,060,971	+2%	+$469M	0.66%	20
2022 Q1	$24.4B	Buy	150,518,780 +4,206,711	+3%	+$682M	0.58%	20
2021 Q4	$19.8B	Buy	146,312,069 +782,554	+0.5%	+$106M	0.45%	32
2021 Q3	$15.7B	Buy	145,529,515 +835,949	+0.6%	+$90.2M	0.39%	42
2021 Q2	$16.3B	Buy	144,693,566 +959,620	+0.7%	+$108M	0.41%	37
2021 Q1	$15.6B	Buy	143,733,946 +1,170,872	+0.8%	+$127M	0.42%	37
2020 Q4	$15.3B	Sell	142,563,074 -1,771,776	-1%	-$190M	0.44%	34
2020 Q3	$12.6B	Sell	144,334,850 -3,051,958	-2%	-$267M	0.42%	40
2020 Q2	$14.5B	Buy	147,386,808 +21,786,239	+17%	+$2.14B	0.51%	32
2020 Q1	$9.57B	Buy	125,600,569 +3,025,849	+2%	+$231M	0.41%	43
2019 Q4	$10.9B	Buy	122,574,720 +811,900	+0.7%	+$71.9M	0.37%	46
2019 Q3	$9.22B	Buy	121,762,820 +239,282	+0.2%	+$18.1M	0.34%	50
2019 Q2	$8.84B	Buy	121,523,538 +679,398	+0.6%	+$49.4M	0.33%	55
2019 Q1	$9.74B	Buy	120,844,140 +260,715	+0.2%	+$21M	0.38%	43
2018 Q4	$11.1B	Buy	120,583,425 +1,821,118	+2%	+$168M	0.5%	32
2018 Q3	$11.2B	Buy	118,762,307 +912,625	+0.8%	+$86.3M	0.44%	35
2018 Q2	$10.9B	Sell	117,849,682 -3,611,083	-3%	-$335M	0.46%	32
2018 Q1	$11.5B	Buy	121,460,765 +1,608,203	+1%	+$152M	0.5%	29
2017 Q4	$11.6B	Buy	119,852,562 +1,905,909	+2%	+$184M	0.51%	30
2017 Q3	$10.5B	Buy	117,946,653 +2,025,980	+2%	+$180M	0.49%	31
2017 Q2	$8.41B	Buy	115,920,673 +3,706,941	+3%	+$269M	0.41%	38
2017 Q1	$7.31B	Buy	112,213,732 +2,676,969	+2%	+$174M	0.38%	40
2016 Q4	$6.86B	Buy	109,536,763 +2,129,277	+2%	+$133M	0.38%	41
2016 Q3	$6.77B	Buy	107,407,486 +3,324,478	+3%	+$210M	0.4%	41
2016 Q2	$6.44B	Buy	104,083,008 +998,196	+1%	+$61.8M	0.4%	44
2016 Q1	$5.89B	Buy	103,084,812 +3,465,191	+3%	+$198M	0.38%	44
2015 Q4	$5.9B	Buy	99,619,621 +394,666	+0.4%	+$23.4M	0.4%	44
2015 Q3	$5.4B	Sell	99,224,955 -1,785,344	-2%	-$97.1M	0.39%	44
2015 Q2	$6.79B	Buy	101,010,299 +8,592,962	+9%	+$577M	0.46%	35
2015 Q1	$5.41B	Buy	92,417,337 +3,573,940	+4%	+$209M	0.37%	47
2014 Q4	$5.81B	Buy	88,843,397 +2,892,424	+3%	+$189M	0.42%	39
2014 Q3	$4.96B	Buy	85,950,973 +232,664	+0.3%	+$13.4M	0.39%	42
2014 Q2	$4.84B	Buy	85,718,309 +1,455,874	+2%	+$82.2M	0.38%	42
2014 Q1	$4.33B	Buy	84,262,435 +1,986,210	+2%	+$102M	0.36%	45
2013 Q4	$4.35B	Buy	82,276,225 +1,696,130	+2%	+$89.6M	0.38%	43
2013 Q3	$3.6B	Buy	80,580,095 +3,060,527	+4%	+$137M	0.35%	43
2013 Q2	$3.2B	Buy	+77,519,568	New	+$3.2B	0.34%	47